Get started
SHANG.FOS.PHARM.GR.H YC 1SHANG.FOS.PHARM.GR.H YC 1SHANG.FOS.PHARM.GR.H YC 1

SHANG.FOS.PHARM.GR.H YC 1

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

08HH chart


Full chart

08HH upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪7.31 B‬ EUR
Dividend yield (indicated)
2.07%
Price to earnings Ratio (TTM)
14.719
Basic EPS (TTM)
0.140 EUR
Net income (FY)
‪373.30 M‬ EUR
Revenue (FY)
‪5.51 B‬ EUR
Shares float
‪473.81 M‬
Beta (1Y)
1.13

Employees


Employees (FY)
‪40.56 K‬
Change (1Y)
+187 +0.46%
Revenue / Employee (1Y)
‪135.94 K‬ EUR
Net income / Employee (1Y)
‪9.20 K‬ EUR

About SHANGHAI FOSUN PHARMACEUTICAL GROUP


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Yi Liu
Website
fosunpharma.com
Headquarters
Shanghai
Founded
1994
ISIN
CNE100001M79
FIGI
BBG007FFXH82
Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises business that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China.

Check out other big names from the same industry as 08HH.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

08HH news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 08HH is 1.801 EUR — it has increased by 0.78% in the past 24 hours. Watch SHANG.FOS.PHARM.GR.H YC 1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SHANG.FOS.PHARM.GR.H YC 1 stocks are traded under the ticker 08HH.
08HH stock has risen by 4.71% compared to the previous week, the month change is a 3.03% rise, over the last year SHANG.FOS.PHARM.GR.H YC 1 has showed a 18.88% increase.
We've gathered analysts' opinions on SHANG.FOS.PHARM.GR.H YC 1 future price: according to them, 08HH price has a max estimate of 2.30 EUR and a min estimate of 1.54 EUR. Watch 08HH chart and read a more detailed SHANG.FOS.PHARM.GR.H YC 1 stock forecast: see what analysts think of SHANG.FOS.PHARM.GR.H YC 1 and suggest that you do with its stocks.
08HH reached its all-time high on Aug 4, 2021 with the price of 8.620 EUR, and its all-time low was 0.270 EUR and was reached on Feb 19, 2009. View more price dynamics on 08HH chart.
See other stocks reaching their highest and lowest prices.
08HH stock is 0.78% volatile and has beta coefficient of 1.13. Track SHANG.FOS.PHARM.GR.H YC 1 stock price on the chart and check out the list of the most volatile stocks — is SHANG.FOS.PHARM.GR.H YC 1 there?
Today SHANG.FOS.PHARM.GR.H YC 1 has the market capitalization of ‪4.86 B‬, it has increased by 0.51% over the last week.
Yes, you can track SHANG.FOS.PHARM.GR.H YC 1 financials in yearly and quarterly reports right on TradingView.
SHANG.FOS.PHARM.GR.H YC 1 is going to release the next earnings report on Sep 2, 2025. Keep track of upcoming events with our Earnings Calendar.
08HH net income for the last half-year is ‪208.35 M‬ EUR, while the previous report showed ‪158.64 M‬ EUR of net income which accounts for 31.33% change. Track more SHANG.FOS.PHARM.GR.H YC 1 financial stats to get the full picture.
Yes, 08HH dividends are paid annually. The last dividend per share was 0.04 EUR. As of today, Dividend Yield (TTM)% is 1.77%. Tracking SHANG.FOS.PHARM.GR.H YC 1 dividends might help you take more informed decisions.
SHANG.FOS.PHARM.GR.H YC 1 dividend yield was 2.64% in 2024, and payout ratio reached 31.12%. The year before the numbers were 1.94% and 30.22% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 3, 2025, the company has ‪40.56 K‬ employees. See our rating of the largest employees — is SHANG.FOS.PHARM.GR.H YC 1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANG.FOS.PHARM.GR.H YC 1 EBITDA is ‪787.11 M‬ EUR, and current EBITDA margin is 14.28%. See more stats in SHANG.FOS.PHARM.GR.H YC 1 financial statements.
Like other stocks, 08HH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANG.FOS.PHARM.GR.H YC 1 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANG.FOS.PHARM.GR.H YC 1 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANG.FOS.PHARM.GR.H YC 1 stock shows the neutral signal. See more of SHANG.FOS.PHARM.GR.H YC 1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.